Price movement over the last 24 hours
Acadia Healthcare Company Inc vs W W Grainger Inc — how do they compare? Acadia Healthcare Company Inc trades at $30.63 (market cap $2.94B), while W W Grainger Inc trades at $1,350.14 (market cap $64.04B). The key difference: W W Grainger Inc is far larger — about 21.8× Acadia Healthcare Company Inc's market cap, and W W Grainger Inc pays a 0.68% dividend while Acadia Healthcare Company Inc pays none. Which is the better fit depends on your goals.
| ACHC | GWW | |
|---|---|---|
Market Cap | $2.94B | $64.04B |
Sector | Health | Technology |
52-Week High | $31.92 | $1.37K |
52-Week Low | $11.68 | $918.18 |
Enterprise Value | $5.45B | $66.13B |
Dividend Yield | — | 0.68% |
Signals from Pluang's Aura AI — not financial advice
ACHC trades at $31.09, down 2.57% today but maintains a bullish technical outlook with strong moving average support. The company shows operational strength with three consecutive earnings beats, though profitability remains challenged with a -32.84% net margin. Analyst consensus is strongly bullish with 68% buy ratings, while recent news highlights the company's strategic shift toward profitability and rising behavioral health demand.
The stock presents a mixed opportunity with strong technical momentum and analyst support offset by persistent profitability challenges. Key catalysts include continued earnings outperformance and successful execution of the turnaround strategy, while risks center on margin pressures and high short interest that could limit upside potential.
GWW trades at $1,370.16, up 2.02% today, showing strong momentum with a bullish technical signal from moving averages. The company reported Q1 2026 EPS of $11.65, beating estimates by 14%, and raised full-year guidance. Revenue growth remains solid at 10.1% year-over-year, with operating margins expanding 110 basis points to 16.7%. Recent news highlights Grainger's 25-year partnership with the American Red Cross and multiple analyst upgrades citing momentum potential.
The outlook remains positive with analyst consensus target of $1,260 suggesting modest upside. Strong profitability metrics (48.1% ROE, 19.66% ROA) support valuation, though elevated P/E of 36.84 warrants monitoring. Key risks include industrial sector cyclicality and margin pressure from rising costs. Institutional sentiment leans cautious with 63% hold ratings despite recent earnings beat.
Trailing returns across standard periods
Acadia Healthcare is a leading provider of behavioral healthcare services across the US and Puerto Rico. It operates a network of psychiatric hospitals, residential treatment centers, and clinics for mental health and addiction recovery.
Read more on ACHC →Grainger is a leading broad-line distributor of maintenance, repair, and operating (MRO) products. It serves millions of customers worldwide through an integrated network of branches and digital platforms.
Read more on GWW →